Join the Diabetes, Type 2 group to help and get support from people like you.
Diabetes, Type 2 News (Page 16)
Related terms: Noninsulin-dependent Diabetes, Type 2 Diabetes, Diabetes, Type 2
Cost Keeps Many Who Need Them From Getting New Weight-Loss Meds
WEDNESDAY, Aug. 7, 2024 (HealthDay news) – Medicare and Medicaid patients are less likely to get cutting-edge weight-loss drugs than people with private insurance are, a new study finds. Medicaid...
Digital Diabetes Prevention Program Cost-Effective for Preventing T2D
TUESDAY, Aug. 6, 2024 – For individuals with prediabetes, a digital diabetes prevention program (d-DPP) is cost-effective compared with an in-person lifestyle intervention for preventing development...
2021 to 2023 Saw Considerable Increase in Semaglutide Fills
MONDAY, Aug. 5, 2024 – From 2021 through 2023, there was a considerable increase in the number of semaglutide fills, according to a research letter published online Aug. 2 in JAMA Health Forum....
Long-Term Low-Carb Diet Efficacious for Treating Dyslipidemia in T2D
FRIDAY, Aug. 2, 2024 – For individuals with type 2 diabetes, long-term low-carbohydrate diets (LCD) are efficacious for treatment of dyslipidemia but do not affect glycemic control, according to a...
Sit a Lot? Exercise Might Offset the Damage to Your Health
FRIDAY, Aug. 2, 2024 – People can offset hours spent sitting around with minutes of active exercise each week, a new study claims. Folks who are sedentary for eight or more hours daily can lower...
Legit Ozempic Sales Soar While Counterfeits Put Patients in Danger
FRIDAY, Aug. 2, 2024 – Two new studies show how eager Americans are to obtain either safe, legitimate versions of Ozempic or counterfeit and potentially dangerous forms of the diabetes/weight-loss...
14 Risk Factors Raise Your Odds for Odds for Dementia
THURSDAY, AUG. 1, 2024 – New research has added two conditions to the list of 12 risk factors that boost the chances of a dementia diagnosis. The good news? You can guard against the development of...
Semaglutide Seems Beneficial for Comorbid T2DM, Tobacco Use Disorder
MONDAY, July 29, 2024 – For patients with type 2 diabetes mellitus (T2DM) and tobacco use disorder (TUD), new use of semaglutide is associated with lower risk of TUD-related health care measures...
FDA Warns of Accidental Overdoses from Compounded Versions of Ozempic
TUESDAY, July 30, 2024 – People taking compounded versions of Ozempic have been overdosing on the drug, the U.S. Food and Drug Administration warns. These ODs typically are due to miscommunications...
Study Looks at Effects of Reducing Intake of Processed Meat, Unprocessed Red Meat
MONDAY, July 29, 2024 – Reductions in processed meat and unprocessed red meat consumption could result in fewer occurrences of type 2 diabetes, cardiovascular disease, colorectal cancer, and...
Certain Abbott Blood Sugar Monitors May Give Incorrect Readings
FRIDAY, July 26, 2024 – Abbott has warned diabetes patients that some of its continuous blood sugar monitoring systems may need to be replaced because of inaccurate readings. "Abbott has recently...
Long-Term Sulfonylurea Use Tied to Impaired Awareness of Hypoglycemia
TUESDAY, July 23, 2024 – The prevalence of impaired awareness of hypoglycemia (IAH) is high among patients using sulfonylureas long term, according to a study published in the July/August issue of...
More Americans With Diabetes Are Turning to Marijuana
WEDNESDAY, July 24, 2024 – As marijuana loses much of its stigma and laws around its use relax, Americans are increasingly consuming it medically and recreationally. Americans with diabetes are no...
FDA Approves Zituvimet XR (sitagliptin and metformin hydrochloride) Extended-Release Tablets for Adults with Type 2 Diabetes
Ahmedabad, India, 19 July 2024 Zydus Lifesciences Limited (including its subsidiaries/ affiliates, hereafter referred to as “Zydus”) has received final approval for its New Drug Application (NDA) fro...
2011 to 2023 Saw Increase in New GLP-1 Receptor Agonist Prescriptions
MONDAY, July 22, 2024 – From 2011 to 2023, there was an increase in new glucagon like peptide 1 receptor agonist (GLP-1RA) prescriptions, according to a research letter published online July 23 in...
Further information
Related condition support groups
Related drug support groups
metformin, Ozempic, Victoza, Mounjaro, Lantus, semaglutide, Trulicity, glipizide, Rybelsus, view more... Farxiga, Jardiance, Lantus Solostar, Humalog, Novolog, liraglutide, Janumet, insulin glargine, tirzepatide, Januvia, insulin lispro, Bydureon, Tresiba, Levemir, dulaglutide, Glucophage, Invokana, insulin degludec, Humulin N